Aadi Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Aadi Bioscience
AADI Stock  USD 2.05  0.05  2.38%   
Aadi Bioscience financial statements provide useful quarterly and yearly information to potential Aadi Bioscience investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Aadi Bioscience financial statements helps investors assess Aadi Bioscience's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aadi Bioscience's valuation are summarized below:
Gross Profit
-27.5 M
Profit Margin
(2.46)
Market Capitalization
97.2 M
Enterprise Value Revenue
1.4174
Revenue
25.1 M
We have found one hundred twenty available fundamental signals for Aadi Bioscience, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Aadi Bioscience prevailing fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The current Market Cap is estimated to decrease to about 46.5 M. The Aadi Bioscience's current Enterprise Value is estimated to increase to about (6.2 M)

Aadi Bioscience Total Revenue

29.41 Million

Check Aadi Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aadi Bioscience's main balance sheet or income statement drivers, such as Other Operating Expenses of 116.3 M, Total Operating Expenses of 112.9 M or Interest Expense of 224.8 K, as well as many indicators such as Price To Sales Ratio of 1.91, Dividend Yield of 0.0164 or PTB Ratio of 0.49. Aadi financial statements analysis is a perfect complement when working with Aadi Bioscience Valuation or Volatility modules.
  
Check out the analysis of Aadi Bioscience Correlation against competitors.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.

Aadi Bioscience Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets159.9 M152.3 M58.7 M
Slightly volatile
Cash75.9 M72.3 M33.2 M
Slightly volatile
Cash And Short Term Investments131.4 M125.2 M51.2 M
Slightly volatile
Common Stock Shares Outstanding32.5 M31 M9.2 M
Slightly volatile
Liabilities And Stockholders Equity159.9 M152.3 M58.7 M
Slightly volatile
Other Stockholder Equity451.8 M430.2 M148.7 M
Slightly volatile
Total Current Assets150.4 M143.3 M56.3 M
Slightly volatile
Short and Long Term Debt Total2.3 M1.5 M2 M
Pretty Stable
Total Current Liabilities31.9 M30.4 M11.4 M
Slightly volatile
Other Assets2.6 M2.5 M744.8 K
Slightly volatile
Non Current Liabilities Total1.3 M958 K1.1 M
Slightly volatile
Total Liabilities32.9 M31.3 M12.5 M
Slightly volatile
Short Term Debt474.1 K499.1 K1.5 M
Very volatile
Common Stock1.5 K2.3 K1.5 K
Slightly volatile
Other Current Liabilities24.2 M23.1 M6.6 M
Slightly volatile
Accounts Payable7.1 M6.8 M2.2 M
Slightly volatile
Other Current Assets4.6 M4.4 M1.7 M
Slightly volatile
Non Current Assets Total9.5 M9 M2.4 M
Slightly volatile
Property Plant And Equipment Net7.2 M6.9 M1.5 M
Slightly volatile
Common Stock Total Equity2.8 K1.8 K2.8 K
Pretty Stable
Property Plant And Equipment Gross7.5 M7.2 M1.6 M
Slightly volatile
Capital Surpluse226.9 M321 M209.5 M
Slightly volatile
Property Plant Equipment2.5 M2.3 M639.2 K
Slightly volatile
Non Current Liabilities Other7.5 M7.2 M2.1 M
Slightly volatile
Other Liabilities4.3 M6.6 M1.8 M
Slightly volatile
Long Term Debt881.6 K991.8 K1.1 M
Slightly volatile
Capital Lease Obligations1 M1.5 M460.7 K
Slightly volatile
Short and Long Term Debt7.2 M8.1 M8.9 M
Slightly volatile
Capital Stock1.6 K1.8 K2 K
Slightly volatile
Intangible Assets3 M3.4 M3.7 M
Slightly volatile

Aadi Bioscience Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses116.3 M110.7 M33 M
Slightly volatile
Selling General Administrative54.7 M52.1 M14.9 M
Slightly volatile
Cost Of Revenue3.4 M3.2 M724.3 K
Slightly volatile
Depreciation And Amortization132.3 K194.3 K106.2 K
Slightly volatile
Selling And Marketing Expenses7.4 M7 M5.8 M
Slightly volatile
Research Development59.1 M56.3 M22.2 M
Slightly volatile
Total Revenue29.4 M28 M18.4 M
Very volatile
Non Operating Income Net Other872.3 K1.3 M478.2 K
Slightly volatile
Non Recurring89.5 M85.3 M30.6 M
Slightly volatile
Interest Income7.9 M7.5 M1.5 M
Slightly volatile
Reconciled Depreciation122.1 K196.7 K53.3 K
Slightly volatile

Aadi Bioscience Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities356.2 K374.9 K20.2 M
Slightly volatile
Depreciation204.1 K194.3 K89.5 K
Slightly volatile
Stock Based Compensation14.4 M13.7 M3.8 M
Slightly volatile
Change To Netincome15.1 M14.4 M5.6 M
Slightly volatile
Net Borrowings1 M1.1 M5.5 M
Slightly volatile
Change Receivables11.3 M12.7 M13.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.912.0118.7737
Pretty Stable
Dividend Yield0.01640.01840.0201
Slightly volatile
Days Sales Outstanding18294.59282
Slightly volatile
Average Payables1.3 M1.3 M808.6 K
Slightly volatile
Stock Based Compensation To Revenue0.470.440.364
Slightly volatile
Capex To Depreciation22.2121.155.0305
Slightly volatile
Payables Turnover0.520.558.6032
Slightly volatile
Sales General And Administrative To Revenue17.4916.666.1457
Slightly volatile
Research And Ddevelopement To Revenue2.192.313.4057
Slightly volatile
Capex To Revenue0.0880.150.0535
Slightly volatile
Cash Per Share6.543.647.7894
Slightly volatile
Days Payables Outstanding6556901.9 K
Pretty Stable
Income Quality0.820.90721.0085
Very volatile
Intangibles To Total Assets0.01930.02170.0237
Slightly volatile
Current Ratio3.14.254.0732
Slightly volatile
Receivables Turnover3.623.992.4547
Slightly volatile
Capex Per Share0.140.130.0473
Slightly volatile
Revenue Per Share0.991.0410.425
Very volatile
Debt To Assets0.01050.0117.4593
Slightly volatile
Days Of Payables Outstanding6556901.9 K
Pretty Stable
Ebt Per Ebit0.830.821.0108
Pretty Stable
Quick Ratio3.14.034.0434
Slightly volatile
Net Income Per E B T1.080.94211.0032
Pretty Stable
Cash Ratio2.492.143.1733
Slightly volatile
Days Of Sales Outstanding18294.59282
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.810.960.993
Slightly volatile
Fixed Asset Turnover4.464.69117
Slightly volatile
Debt Ratio0.01050.0117.4593
Slightly volatile
Price Sales Ratio1.912.0118.7737
Pretty Stable
Asset Turnover0.240.210.2697
Slightly volatile
Gross Profit Margin0.971.020.9048
Pretty Stable

Aadi Bioscience Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap46.5 M48.9 M109 M
Very volatile

Aadi Fundamental Market Drivers

Cash And Short Term Investments108.8 M

Aadi Upcoming Events

26th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Aadi Bioscience Financial Statements

Investors use fundamental indicators, such as Aadi Bioscience's revenue or net income, to determine how well the company is positioned to perform in the future. Although Aadi Bioscience's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue21.2 M22.2 M
Cost Of Revenue3.2 M3.4 M
Total Revenue28 M29.4 M
Stock Based Compensation To Revenue 0.44  0.47 
Sales General And Administrative To Revenue 16.66  17.49 
Research And Ddevelopement To Revenue 2.31  2.19 
Capex To Revenue 0.15  0.09 
Revenue Per Share 1.04  0.99 
Ebit Per Revenue(3.40)(3.57)

Currently Active Assets on Macroaxis

VVisa Class A
CRMSalesforce
CRMSalesforce
MSFTMicrosoft
VVisa Class A
When determining whether Aadi Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Aadi Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Aadi Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Aadi Bioscience Stock:
How To Invest In Aadi
Details
Is Aadi Stock a good investment?
Details
What is Aadi Bioscience's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Aadi Bioscience Correlation against competitors.
For more detail on how to invest in Aadi Stock please use our How to Invest in Aadi Bioscience guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aadi Bioscience. If investors know Aadi will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aadi Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.28)
Revenue Per Share
0.929
Quarterly Revenue Growth
0.21
Return On Assets
(0.35)
Return On Equity
(0.66)
The market value of Aadi Bioscience is measured differently than its book value, which is the value of Aadi that is recorded on the company's balance sheet. Investors also form their own opinion of Aadi Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Aadi Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aadi Bioscience's market value can be influenced by many factors that don't directly affect Aadi Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Aadi Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aadi Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aadi Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY